Skip to main content

Table 2 Clinical characteristics of adults with RSV-associated hospitalization, 2015–2017

From: Relationship between neighborhood census-tract level socioeconomic status and respiratory syncytial virus-associated hospitalizations in U.S. adults, 2015–2017

Clinical characteristics (number of patients), n (%)
  Percent of individuals living below the poverty level within a census tract Total (n = 1713)
Underlying conditions 0–4.9%
(n = 397)
5–9.9%
(n = 535)
10–19.9%
(n = 438)
≥20%
(n = 343)
 
Any underlying medical condition 377 (95) 508 (95) 409 (93) 321 (94) 1615 (94)
Pulmonary disease1 166 (42) 279 (52) 211 (39) 215 (63) 871 (51)
Obesity (BMI ≥30) 203 (51) 244 (46) 212 (48) 158 (46) 817 (48)
Chronic metabolic disease2 171 (43) 269 (32) 189 (35) 163 (48) 792 (46)
Cardiovascular disease3 170 (43) 245 (46) 182 (42) 156 (45) 753 (44)
Renal disease4 95 (24) 163 (30) 126 (29) 106 (31) 490 (29)
Immunocompromised5 104 (26) 136 (25) 89 (17) 93 (27) 422 (25)
Neurologic disease6 87 (22) 105 (20) 91 (17) 64 (19) 347 (20)
Liver disease7 20 (5) 29 (7) 22 (5) 30 (9) 101 (6)
Blood disorders/hemoglobinopathy8 16 (4) 17 (3) 16 (3) 10 (3) 59 (3)
Rheumatologic disease 9 18 (5) 17 (3) 15 (3) 22 (6) 72 (4)
Substance Use
 Smoker (current) 39 (10) 64 (12) 88 (20) 101 (29) 292 (17)
 Smoker (former) 153 (39) 178 (33) 131 (30) 105 (31) 567 (33)
 Smoker (no/unknown) 205 (52) 293 (55) 219 (50) 137 (40) 854 (50)
 Alcohol abuse (current) 8 (2) 11 (2) 14 (3) 25 (7) 58 (3)
 Alcohol abuse (former) 13 (3) 16 (3) 10 (2) 13 (4) 52 (3)
 Alcohol abuse (no/unknown) 376 (95) 508 (95) 414 (95) 305 (89) 1603 (94)
 Substance abuse (current) 5 (1) 8 (1) 10 (2) 28 (8) 51 (3)
 Substance abuse (former) 2 (1) 3 (1) 2 (0) 9 (3) 16 (1)
 Substance abuse (no/unknown) 390 (98) 524 (98) 426 (98) 306 (89) 1646 (96)
Indicators of Severe Illness
 Hospital stay > 7 days 103 (26) 110 (21) 106 (24) 103 (30) 422 (25)
 ICU admission 86 (22) 92 (17) 86 (20) 80 (23) 344 (20)
 Need for mechanical ventilation 32 (8) 39 (7) 35 (8) 37 (11) 143 (8)
 Death 19 (5) 28 (5) 21 (5) 18 (5) 86 (5)
  1. 1asthma, COPD, chronic bronchitis, emphysema, CF, Chronic respiratory failure, active TB, other
  2. 2diabetes, thyroid disease, other endocrinopathy
  3. 3coronary artery disease, congestive heart failure, cardiomyopathy, prior coronary artery bypass graft, cerebral vascular accident/stroke/transient ischemic attack, atherosclerosis
  4. 4chronic kidney disease, end-stage renal disease, glomerulonephritis, nephrotic syndrome, other
  5. 5cancer, complement deficiency, HIV, AIDS, immunoglobulin deficiency, any immunosuppressive therapy, status-post solid organ transplant, s/p bone marrow transplant, receipt of steroid therapy, other
  6. 6cerebral palsy, cognitive dysfunction, dementia, developmental delay, Trisomy 21, paralysis, seizures, muscular dystrophy, multiple sclerosis, myasthenia gravis, other
  7. 7cirrhosis, hepatitis B or C, other
  8. 8aplastic anemia, Sickle cell disease, asplenia, other
  9. 9lupus, Juvenile idiopathic arthritis, rheumatoid arthritis, psoriasis, polymyositis, polymyalgia, polyarteritis nodosa, vasculitis, other